As of 2026-03-19, the EV/EBITDA ratio of Avanos Medical Inc (AVNS) is 11.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVNS's latest enterprise value is 636.59 mil USD. AVNS's TTM EBITDA according to its financial statements is 55.80 mil USD. Dividing these 2 quantities gives us the above AVNS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 15.8x | 14.0x |
| Forward P/E multiples | 14.6x - 16.1x | 15.5x |
| Fair Price | 16.35 - 19.04 | 17.50 |
| Upside | 21.5% - 41.5% | 30.0% |
| Date | EV/EBITDA |
| 2026-03-18 | 11.41 |
| 2026-03-17 | 11.53 |
| 2026-03-16 | 11.71 |
| 2026-03-13 | 11.60 |
| 2026-03-12 | 11.38 |
| 2026-03-11 | 11.36 |
| 2026-03-10 | 11.12 |
| 2026-03-09 | 11.13 |
| 2026-03-06 | 11.27 |
| 2026-03-05 | 11.68 |
| 2026-03-04 | 11.76 |
| 2026-03-03 | 11.85 |
| 2026-03-02 | 11.84 |
| 2026-02-27 | 11.94 |
| 2026-02-26 | 12.27 |
| 2026-02-25 | 12.16 |
| 2026-02-24 | 11.56 |
| 2026-02-23 | 12.88 |
| 2026-02-20 | 13.08 |
| 2026-02-19 | 12.87 |
| 2026-02-18 | 12.86 |
| 2026-02-17 | 12.62 |
| 2026-02-13 | 12.61 |
| 2026-02-12 | 12.49 |
| 2026-02-11 | 12.79 |
| 2026-02-10 | 12.46 |
| 2026-02-09 | 12.07 |
| 2026-02-06 | 12.35 |
| 2026-02-05 | 11.73 |
| 2026-02-04 | 11.78 |
| 2026-02-03 | 11.38 |
| 2026-02-02 | 11.42 |
| 2026-01-30 | 11.29 |
| 2026-01-29 | 10.93 |
| 2026-01-28 | 10.90 |
| 2026-01-27 | 11.15 |
| 2026-01-26 | 11.16 |
| 2026-01-23 | 11.10 |
| 2026-01-22 | 11.11 |
| 2026-01-21 | 10.91 |
| 2026-01-20 | 10.48 |
| 2026-01-16 | 10.48 |
| 2026-01-15 | 10.48 |
| 2026-01-14 | 10.08 |
| 2026-01-13 | 9.69 |
| 2026-01-12 | 10.17 |
| 2026-01-09 | 10.48 |
| 2026-01-08 | 10.41 |
| 2026-01-07 | 9.94 |
| 2026-01-06 | 9.97 |